Cite
Thyroid dysfunction related to vascular endothelial growth factor receptor tyrosine kinase inhibitors: A real‐world study based on FAERS.
MLA
Liao, Xiaolan, et al. “Thyroid Dysfunction Related to Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Real‐world Study Based on FAERS.” Journal of Clinical Pharmacy & Therapeutics, vol. 46, no. 5, Oct. 2021, pp. 1418–25. EBSCOhost, https://doi.org/10.1111/jcpt.13472.
APA
Liao, X., Liu, Z., & Song, H. (2021). Thyroid dysfunction related to vascular endothelial growth factor receptor tyrosine kinase inhibitors: A real‐world study based on FAERS. Journal of Clinical Pharmacy & Therapeutics, 46(5), 1418–1425. https://doi.org/10.1111/jcpt.13472
Chicago
Liao, Xiaolan, Zhihong Liu, and Hongtao Song. 2021. “Thyroid Dysfunction Related to Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Real‐world Study Based on FAERS.” Journal of Clinical Pharmacy & Therapeutics 46 (5): 1418–25. doi:10.1111/jcpt.13472.